WASO KOSHIRICE ACNE CALMING TREATMENT
Natural health product licensed in Canada
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Acide 2-hydroxybenzoïque Source : Acide salicylique | 0.5 % |
Non-medicinal ingredients
Glycérine, Polymère croisé d'acrylates/acrylate d'alkyle en C10 à 30, Phénoxyéthanol, PEG/PPG-14/7 diméthyl éther, Dipropylène glycol, Extrait de pelures de Citrus depressa, Eau, Erythritol, Hydroxytoluène butylé, PEG-32, Butylène glycol, Hydroxyde de potassium, Alcool isostéarylique, Métaphosphate de sodium, Extrait de riz hydrolysé, Copolymère de carbomère, Acide benzoïque, PEG-6, Extrait de racine de Paeonia albiflora, Glycyrrhizate de dipotassium, Diméthicone, PEG-240/HDI copolymère de bis-décyltetradéceth-20 éther
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adolescentes | minimum: 12 years ; maximum: 17 years | Not specified | Not specified |
| Adultes | minimum: 18 years | Not specified | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
For the treatment/management of acne.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Product record
- Other names
- ACNE CALMING TREATMENT, KOSHIRICE ACNE CALMING TREATMENT
- Licence holder
- Shiseido (Canada) Inc.
- NPN or DIN-HM
- 80104734
- Status
- Active licence
- Licence date
- 2 October 2020
- Revision date
- Not provided
- Form
- Gel
- Route of administration
- Topique
- Application type
- Officinale
Source
Official Health Canada record, licence 80104734
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “WASO KOSHIRICE ACNE CALMING TREATMENT (Shiseido (Canada) Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80104734-waso-koshirice-acne-calming-treatment, updated 2 October 2020.